Patient#	Sample#	ABCC1:(ABCC1, protein),	ERK1-2:(ERK1-2, protein),	Gi family:(Gi family, protein),	PKC:(PKC, protein),	S1P1:(S1P1, protein),	ERK1-2-active	PTGS2:(PTGS2, protein),	PAK1	PDGFB-D/PDGFRB/PLCgamma1	SPHK1:(PDGFB-D/PDGFRB/PLCgamma1, active),(SPHK1, protein),(calcium-dependent phospholipase C activity, active),	S1P:(ABCC1, active),(SPHK1, active),(sphingosine, active),	S1P1/S1P:(PKC, active),(S1P, active),(S1P1, active),	PLCB2:(PLCB2, protein),(S1P1/S1P, active),	RhoA/GTP:(RhoA/GDP, active),(S1P1/S1P, active),	S1P1/S1P/Gi:(Gi family, active),(S1P1/S1P, active),	S1P1/S1P/PDGFB-D/PDGFRB:(PDGFB-D/PDGFRB, active),(S1P1/S1P, active),	receptor internalization:(S1P1/S1P, active),	PLCG1:(PLCG1, protein),(S1P1/S1P/Gi, active),	endothelial cell migration:(PAK1, active),(RhoA/GTP, active),(alphaV/beta3 Integrin, active),	negative regulation of T cell proliferation:(S1P1/S1P/Gi, active),	negative regulation of cAMP metabolic process:(S1P1/S1P/Gi, active),	
